Dr Daniel Goldberg, a pioneer in Laser eye surgery and the director of vision correction at the Atlantic Laser Vision Center was awarded ‘Top Doctor” by Castle Connolly Medical.

Castle Connolly Medical Ltd. is a healthcare research and information company founded in 1991. Their goal is to help guide consumers to America’s top doctors and top hospitals using a detailed survey and comprehensive research

Dr Goldberg’s award recognizes him as one of the best doctors in the field of Ophthalmology. Dr Goldberg is credited as one of the first laser eye surgeons to help bring advanced technologies in the field to the United States. Dr. Daniel Goldberg has a rare dual certification from both the Council for Refractive Surgery Quality Assurance (an independent, nonprofit, patient and consumer health organization that evaluates and verifies the quality of the surgeries provided by select refractive surgeons in the United States), and the ABES( American Board of Eye Surgeons ). Nationwide, there are less than 10 LASIK surgeons with dual certification by ABES and CRSQA.

Dr Goldberg was a member of the elite team of doctors who performed clinical trials of LASIK in its early stages. This research led to FDA approval of LASIK. In 2000, at the ASCRS(American Society of Cataract and Refractive Surgeons) national meeting, the first large scale study of LASIK monovision was presented by Goldberg and the published paper appeared in 2001 in the Journal of Cataract and Refractive Surgery. Further research by Goldberg resulted in another large study of LASIK monovision which was published in 2003—this work compared results in far-sighted eyes as well as near-sighted eyes. Based on this research, Goldberg made presentations at national meetings on “Succeeding with LASIK Monovision” and taught courses at the ASCRS meetings on “Surgical correction of Presbyopia.”

In April of 2008, Dr Goldberg was recognized at the inaugural training session for Custom Vue Monovision in Chicago for helping to set the stage for the FDA approval of LASIK monovision.

For more information, visit www.goldberg4lasik.com

Dr. Daniel Goldberg, a laser eye surgeon and director of laser eye surgery at the Atlantic Laser Vision Center has been named to the 2009-2010 Best Doctors in America.  A peer review survey by thousands of doctors determines which physicians are included.  Since doctors cannot buy listings in the directory, being selected is an exclusive honor for medical professionals.

Dr. Daniel Goldberg specializes in comprehensive refractive surgery including LASIK eye surgery and refractive intraocular lens and cataract surgery.  He was a member of the elite team of doctors who performed clinical trials of LASIK in its early stages. This research led to FDA approval of LASIK.  

Dr Goldberg has 25 years of experience in refractive surgery and has performed over 10,000 LASIK surgery procedures.  He recently became the first New Jersey eye surgeon to use the implantable contact lens (ICL) – a new technology to correct nearsightedness in individuals with extremely high prescriptions. 

In 2008, Dr Goldberg was also recently honored by Castle Connolly Medical who presented him with their annual ‘Top Doctor” award which recognizes him as one of the best doctors in the field of Ophthalmology.  Then, in April of 2008, Dr Goldberg was again recognized at the inaugural training session for Custom Vue Monovision in Chicago for helping to set the stage for the FDA approval of LASIK monovision.

Dr Goldberg is constantly on the forefront of groundbreaking technology and innovations in the field of Ophthalmology.  Currently Dr Goldberg is leading a worldwide study testing the effectiveness of using 5% Betadine irrigation for the treatment of acute EKC- a common, worldwide, highly contagious and often severe form of conjunctivitis with the potential for long term visual impairment due to corneal involvement.  Ophthalmologists around the world are invited to register to participate in the Betadine for EKC study and can do so by visiting http://www.betadineforekc.com/submission-process.aspx.   

More information on Dr Daniel Goldberg is available at http://www.goldberg4lasik.com/

Dr Daniel Goldberg, a leading New Jersey ophthalmologist is coordinating a new study to measure the effectiveness of using 5% Betadine irrigation for treatment of acute EKC- a common, worldwide, highly contagious and often severe form of conjunctivitis with the potential for long term visual impairment due to corneal involvement. 

The purpose of the new study is to confirm the effectiveness of this protocol and to expand the awareness amongst eye care professionals of this inexpensive treatment for EKC. 

 The treatment of EKC using betadine has been widely debated for years, but new research is shedding positive light on the treatment.  The Ocular Surgery News website, www.osnsupersite.com, recently interviewed Dr Goldberg about his new study and about using betadine as a treatmentn for EKC.

To read the full interview and article on the Ocular Surgery News website, visit http://www.osnsupersite.com/view.aspx?rid=41471

Participation in the study is open to ophthalmologists, US and international, who agree to follow the protocol and report clinical results thru the Betadine for EKC website (http://www.betadineforekc.com/Default.aspx ). The initial phase will be collecting data thru October 1, 2009, and it is anticipated that subsequently there will be modifications to the protocol and study design.

For more information about the new study, please visit http://www.betadineforekc.com/the-study.aspx

Information on registration is available at http://www.betadineforekc.com/submission-process.aspx